Vein Graft Stenosis
- PMID: 29763122
- Bookshelf ID: NBK499947
Vein Graft Stenosis
Excerpt
Bypass surgery with a greater saphenous vein graft or another alternative autologous venous graft is a well-established treatment of peripheral arterial disease in the lower limbs. A wide spectrum of peripheral arterial disease with different underlying causalities, including chronic limb-threatening ischemia, intermittent claudication, peripheral limb aneurysms, and major arterial trauma, might be managed with bypass procedures. Bypass surgery has satisfactory outcomes, considering limb preservation and long-term graft patency rates. However, the possibility of vein graft failure due to stenoses significantly limits the durability of the procedure. Diagnosing stenoses through clinical and ultrasonographic surveillance, followed by treatment, avoids the grafts' complete occlusion.
The long-term patency and success of vein grafts in bypass surgery remain challenging due to their accelerated atherosclerotic rates compared to their arterial counterparts. Preventing vein graft stenosis (VGS) is the cornerstone of management and includes tight control of blood pressure, blood sugars, lipid levels, body weight, and smoking cessation. Nearly all patients with vein grafts should be treated with daily aspirin and statin. Further anticoagulation and antiplatelet therapy are determined by specific interventions performed and individualized patient factors. Angina is the most common presentation of VGS following coronary artery bypass grafting (CABG). VGS presents as rest pain, non-healing wounds, and claudication in the peripheral vascular system. If revascularization is necessary, endovascular therapy or surgical bypass should be offered to improve the arterial circulation of the obstructed native vessel. Endovascular therapy of the vein graft itself may be attempted first to improve the primary or secondary patency.[10] An open approach is reserved for multivessel disease or patients for whom endovascular methods are impossible. This topic discusses VGS in the context of patients following CABG or peripheral artery bypass grafting (PABG) using the great saphenous vein as the most common venous conduit.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996 Sep;28(3):616-26. - PubMed
-
- Sanz G, Pajarón A, Alegría E, Coello I, Cardona M, Fournier JA, Gómez-Recio M, Ruano J, Hidalgo R, Medina A. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC). Circulation. 1990 Sep;82(3):765-73. - PubMed
-
- Gavaghan TP, Gebski V, Baron DW. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation. 1991 May;83(5):1526-33. - PubMed
-
- Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997 Jan 16;336(3):153-62. - PubMed
Publication types
LinkOut - more resources
Full Text Sources